FindTrial
Sign In

Genetic Screening Project for Neonatal Inborn Disorders in China

Genetic Screening Project for Neonatal Inborn Disorders in China

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100041773
Enrollment
Unknown
Registered
2021-01-05
Start date
2021-01-15
Completion date
Unknown
Last updated
2021-03-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal Inborn Disorders

Interventions

case series:Nil

Sponsors

The Children's Hospital of Zhejiang University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a.Newborns have or will be screened by tandem mass spectrometry; b.Singleton fetus; c.The parents are healthy and without history of serious acute or chronic diseases and genetic diseases; d.Parents signs the informed consent and participate voluntarily; e.Be followed up until the end of the project.

Exclusion criteria

Exclusion criteria: a.Parents are not Chinese; b.The infant is older than 28 days; c.Cannot provid 2x8mm blood spots; d.Assisted pregnancy (including IVF-ET, ICSI pregnancy) and newborns who undergo PGS/PGD during pregnancy.

Design outcomes

Primary

MeasureTime frame
Neonatal tandem mass spectrometry screening;Next generation sequencing;Newborn screening;—

Countries

China

Contacts

Public ContactZhao Zhengyan

The Children's Hospital of Zhejiang University School of Medicine

zhaozy@zju.edu.cn+86 13805722351

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026